News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
The Washington Post ran two feature articles profiling Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery.
The foundational work that enabled the use of messenger RNA (mRNA) in vaccine development that they're receiving the 2021 Dr. Paul Janssen Award for Biomedical Research,
Drs. Weissman and Karikó’s mRNA technology is recognized for enabling rapid development of highly effective COVID-19 vaccines.
Penn announced that it has made a $100 million commitment in its School of Engineering and Applied Science to establish the Center for Precision Engineering for Health.
Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery at Penn, have been awarded multiple prestigious prizes.
iladelphia landed a spot in the overall top 30 of Startup Genome's Global Startup Ecosystem Report. The city scored highest for its market reach and talent.
Jean Bennett, who designed and co-developed Luxturna, approved in 2018 for a rare form of blindness, had kept building new gene therapies for eye diseases at her University of Pennsylvania lab.
National Inventors Hall of Fame, in partnership with the United States Patent and Trademark Office, is excited to announce the 2022 Class of Inductees.
With an NSF grant, Penn Engineering researchers are developing a new manufacturing technique that would be able to produce mRNA sequences in a way that removes the need for cryogenic temperatures.
long with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma.